Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules
Both companies have been selected for stand-by production by German government
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
The expansion positions Cambrex with the largest and most advanced API facility in the United States
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products
Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle
Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms
Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis
Subscribe To Our Newsletter & Stay Updated
